RECRUITING

Guided Meditation During Radiation Therapy for Brain Tumors

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this interventional treatment study is to assess the anxiolytic effect of providing guided meditation during radiation treatment (RT) in patients with brain tumors. The main question it aims to answer is: • What is the change in acute anxiety in participants receiving the mindfulness intervention during radiation therapy compared to standard of care control conditions? Participants will be asked to participate in a 5-minute, audio-recorded mindfulness practice that will be played during the administration of each RT session. Researchers will compare this intervention to standard of care (no intervention) during RT.

Official Title

An Interventional Trial Using Guided Meditation During Radiation Therapy for Brain Tumors

Quick Facts

Study Start:2024-02-29
Study Completion:2028-01-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06165653

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participant aged ≥ 18 years.
  2. * Radiologically confirmed tumor of the brain. Note: Participants may have tumor resected after diagnosis.
  3. * Eligible to undergo radiation treatment for brain tumor for 25-33 treatments.
  4. * Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
  5. * Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
  6. * MoCA mini score ≥ 11
  7. * Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.
  1. * Active suicidal ideation or active psychotic state in the opinion of the investigator.
  2. * An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
  3. * Prior radiation therapy to the brain.
  4. * Inability to understand and/or speak the English language.

Contacts and Locations

Study Contact

Rachel Kingsford
CONTACT
801-585-0115
rachel.kingsford@hci.utah.edu

Principal Investigator

Lindsay Burt, MD
PRINCIPAL_INVESTIGATOR
Huntsman Cancer Institute/ University of Utah

Study Locations (Sites)

Huntsman Cancer Institute
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Utah

  • Lindsay Burt, MD, PRINCIPAL_INVESTIGATOR, Huntsman Cancer Institute/ University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-29
Study Completion Date2028-01-15

Study Record Updates

Study Start Date2024-02-29
Study Completion Date2028-01-15

Terms related to this study

Additional Relevant MeSH Terms

  • Brain Neoplasms